Elkem (ELK) Q3 & Capital markets update 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 & Capital markets update 2026 earnings summary
29 Oct, 2026Executive summary
Q3 operating income was NOK 3,587 million and EBITDA NOK 554 million, down 2% and 14% YoY, respectively; EBITDA margin was 15%.
Foundry Alloys and Carbon supported results, while Silicon remained pressured by weak silicon and ferrosilicon prices.
Priorities include cost competitiveness, protecting existing positions, and selective profitable growth; the through-cycle EBITDA margin target is above 20%.
Financial highlights
Q3 EBIT was NOK 312 million; profit for the period was NOK 319 million and EPS NOK 0.87.
YTD operating income was NOK 10,956 million and EBITDA NOK 1,393 million; YTD EPS was NOK -1.18, impacted by discontinued-operation losses.
Q3 operating cash flow was NOK 421 million; YTD operating cash flow was NOK 1,368 million, supported by working-capital improvements.
Cost actions reduced headcount by 400 against a target of 300 and cut indirect costs by NOK 600 million; annual savings are expected to exceed NOK 600 million.
Outlook and guidance
Q4 Silicon results are expected to remain stable; Foundry Alloys stable with seasonally lower sales, and Carbon modestly improved as some markets recover.
Silicon prices rose modestly in Q3 and early Q4; further normalization would strengthen the 2027 outlook, while Q4 impact is limited by timing.
Cost reductions are expected to support results; EU protective measures could improve market conditions.
The 2030 target to reduce CO2 emissions by 25% remains under pressure from low-priced imports without CO2 costs.
Latest events from Elkem
- Cost reductions, equity raise, and refinancing drive improved financial stability amid market headwinds.ELK
Q2 2026 - EBITDA fell 65% year-over-year as transformation, cost cuts, and refinancing reshape the business.ELK
Q1 2026 - Portfolio reshaping and cost cuts position the company for focused growth amid market challenges.ELK
DNB Carnegie Small & Medium Enterprises Conference presentation - Silicones division sale drives transformation, cost cuts, and growth focus amid challenging markets.ELK
JP Morgan European Chemicals Forum presentation - All agenda items, including the Bluestar share deal and capital decrease, were approved.ELK
EGM 2026 - Silicones division sale to Bluestar and weak Q4 2025 results mark a major transformation.ELK
Q4 2025 - Strong financial performance and strategic investments drive sustainable growth.ELK
SEB Nordic Seminar presentation - EBITDA hit NOK 1,235 million, up 131% year-over-year, driven by Silicones and cost programs.ELK
Q3 2024 - EBITDA stable at NOK 1,030m; net profit up on tax assets, Silicones improved despite weak demand.ELK
Q2 2024